Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

DNA analysis by flow cytometry in malignant pleural mesothelioma: relationship to histology and survival.

Dazzi H, Thatcher N, Hasleton PS, Chatterjee AK, Lawson RA.

J Pathol. 1990 Sep;162(1):51-5.

PMID:
2231193
2.

Diploid predominance and prognostic significance of S-phase cells in malignant mesothelioma.

Pyrhönen S, Laasonen A, Tammilehto L, Rautonen J, Anttila S, Mattson K, Holsti LR.

Eur J Cancer. 1991;27(2):197-200.

PMID:
1827288
3.

Prognostic significance of DNA aneuploidy in diffuse malignant mesothelioma.

Isobe H, Sridhar KS, Doria R, Cohen F, Raub WA, Saldana M, Krishan A.

Cytometry. 1995 Jan 1;19(1):86-91.

4.

Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma.

Emri S, Akbulut H, Zorlu F, Dinçol D, Akay H, Güngen Y, Içli F.

Lung Cancer. 2001 Aug-Sep;33(2-3):109-14.

PMID:
11551405
5.

Epithelioid pleural mesotheliomas and pulmonary adenocarcinomas: a comparative DNA flow cytometric study.

el-Naggar AK, Ordonez NG, Garnsey L, Batsakis JG.

Hum Pathol. 1991 Oct;22(10):972-8.

PMID:
1842386
6.

Relationship between DNA ploidy and survival in patients with primary breast cancer.

Eskelinen MJ, Pajarinen P, Collan Y, Pesonen E, Alhava E, Kettunen K, Nordling S.

Br J Surg. 1989 Aug;76(8):830-4.

PMID:
2765840
7.
9.

Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.

Lanza G, Gafà R, Santini A, Maestri I, Dubini A, Gilli G, Cavazzini L.

Cancer. 1998 Jan 1;82(1):49-59.

PMID:
9428479
10.

DNA flow cytometry in surgically treated lung cancer--prognostic significance.

Ikonen JT, Ojala A, Salenius JP, Mattila J, Riekkinen H, Wigren T.

Scand Cardiovasc J. 1999;33(4):228-33.

PMID:
10517210
11.
12.

[DNA ploidy and cell kinetics in cancer of the rectum].

Roseano M, Turoldo A, Balani A, Tonello C, Desinan L, Bussani R.

Ann Ital Chir. 1994 May-Jun;65(3):319-29. Italian.

PMID:
7887585
13.

Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.

Lee KH, Lee JS, Lee JH, Kim SW, Suh C, Kim WK, Kim SH, Min YI, Kim BS, Park KC, Lee MS, Sun HS.

Br J Cancer. 1999 Apr;79(11-12):1727-35.

14.

Flow cytometric analysis of DNA content in human ovarian cancers.

Erba E, Ubezio P, Pepe S, Vaghi M, Marsoni S, Torri W, Mangioni C, Landoni F, D'Incalci M.

Br J Cancer. 1989 Jul;60(1):45-50.

15.

Image cytometry: an aid for cytological diagnosis of pleural effusions.

Osterheld MC, Liette C, Anca M.

Diagn Cytopathol. 2005 Mar;32(3):173-6.

PMID:
15690335
16.

DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.

Kühn W, Kaufmann M, Feichter GE, Rummel HH, Schmid H, Heberling D.

Gynecol Oncol. 1989 Jun;33(3):360-7.

PMID:
2722063
17.

[Flow cytometry and malignant pleural mesotheliomas. Value in the histologic and cytologic diagnosis].

Courtin P, Foulet A, Sartiaux C, Gosselin B.

Arch Anat Cytol Pathol. 1993;41(5-6):229-31. Review. French.

PMID:
8135584
18.

The influence of age on the DNA ploidy levels of breast tumours.

Taylor IW, Musgrove EA, Friedlander ML, Foo MS, Hedley DW.

Eur J Cancer Clin Oncol. 1983 May;19(5):623-8.

PMID:
6683634
19.

DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas.

Karlsson M, Boeryd B, Carstensen J, Kågedal B, Wingren S.

Br J Cancer. 1995 Jan;71(1):177-81.

20.

Spectrum of peritoneal mesothelioma in childhood: clinical and histopathologic features, including DNA cytometry.

Niggli FK, Gray TJ, Raafat F, Stevens MC.

Pediatr Hematol Oncol. 1994 Jul-Aug;11(4):399-408.

PMID:
7947012

Supplemental Content

Support Center